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Abstract Patients with an acute basilar artery occlusion
(BAO) have a high risk of long-lasting disability and death.
Only limited data are available on functional outcome in
elderly patients with BAO. Using data from the Basilar
Artery International Cooperation Study, we aimed to
determine outcomes in patients C75 years. Primary out-
come measure was poor functional outcome (modified
Rankin scale score 4–6). Secondary outcomes were death,
insufficient vessel recanalization (defined as thrombolysis
in myocardial infarction score 0–1) and symptomatic
intracranial hemorrhage (SICH). Patients were divided into
four age-groups, based on quartiles: 18–54, 55–64, 65–74,
and C75 years. Outcomes were compared between patients
C75 years and patients aged 18–54 years. Risk ratios with
corresponding 95 % confidence intervals (CI) were calcu-
lated and Poisson regression analyses were performed
to calculate adjusted risk ratios (aRR). We included
619 patients [18–54 years n = 153 (25 %), 55–64 years
n = 133 (21 %), 65–74 years n = 171 (28 %), and
C75 years n = 162 (26 %)]. Compared with patients aged
18–54 years, patients C75 years were at increased risk of
poor functional outcome [aRR 1.33 (1.14–1.55)] and death
[aRR 2.47 (1.75–3.51)]. Nevertheless, 35/162 (22 %, 95 %
CI 15–28 %) of patients C75 years had good functional
outcome. No significant differences between age groups
were observed for recanalization rate and incidence of
SICH. Although patients C75 years with BAO have an
increased risk of poor outcome compared with younger
patients, a substantial group of patients C75 years survives
with a good functional outcome.
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Introduction
Patients with an acute basilar artery occlusion (BAO) have
a high risk of long-lasting disability and death [1, 2].
Although higher age, analyzed as a continuous variable,
has been associated with poor functional outcome after
BAO, only limited data are available on functional out-
come in elderly patients [3–8]. One small case series
suggested that all patients C75 years have poor functional
outcome [6]. In another study, the eldest surviving patient
in whom recanalization was successful was 63-year-old
[3]. We analysed data from the Basilar Artery International
Cooperation Study (BASICS) to determine outcomes in
patients with BAO C75 years.
Methods
BASICS is a prospective, observational, registry of 619
consecutive patients C18 years with an acute symptomatic
BAO [2, 9]. The protocol was approved by the ethics
committee of the University Medical Center Utrecht, the
Netherlands. Embolic BAO was defined as complete
recanalization on follow-up and no indication of dissection,
or maximum deficit from onset and cardiac or vertebral
source of embolism, or maximum deficit from onset with
complete absence of other atherosclerotic cerebrovascular
lesions. Atherosclerotic BAO was defined as known
symptomatic basilar artery stenosis ([50 %) prior to
occlusion, or residual stenosis after recanalization and no
evidence of cardiac or vertebral artery source of embolism,
or prior TIAs or stroke in the basilar artery territory and no
evidence of cardiac or vertebral artery source of embolism.
Dissections were not predefined, but scored according to
the investigators.
Primary outcome was poor functional outcome after
1 month [predefined as modified Rankin scale (mRS) score
4–6]. Secondary outcomes were death, insufficient vessel
recanalization [defined as thrombolysis in myocardial
infarction (TIMI) score 0–1] and symptomatic intracranial
hemorrhage (SICH). We also investigated if our conclu-
sions changed if poor functional outcome was defined as an
mRS of 3–6. SICH was not predefined by the registry, and
the reporting of SICH was done on the basis of each
investigator’s judgment. For the purpose of this study,
patients were divided into four age-groups, based on
quartiles: 18–54, 55–64, 65–74, and C75 years. Outcomes
were compared between patients C75 years and patients
aged 18–54 years. Risk ratios (RR) and corresponding
95 % confidence intervals (CI) were calculated. Variables
that affected the crude risk ratio most were used simulta-
neously in Poisson regression analyses to calculate adjusted
risk ratios (aRR) [2]. Missing baseline data (\5 % for each
variable) were imputed with regression imputation [10].
Finally, we explored the incidence of poor functional
outcome in patients 75–79, 80–84, 85–89, and 90 years or
older.
Results
Baseline characteristics are listed in Table 1. In total, 162
patients (26 % of total cohort) were C75 years. In this
group of patients, the most common cause of stroke was
embolism and 64 % had an NIHSS score [20. Treatment
of any kind was initiated in 148 patients (91 %).
Modified Rankin Scale scores for all age groups are
presented in Fig. 1. Patients C75 years had a higher risk
of poor functional outcome [aRR 1.33 (1.14–1.55),
Table 2] and death [aRR 2.47 (1.75–3.51), Table 3] than
patients aged 18–54 years. Nevertheless, 35 patients
(22 %, 95 % CI 15–28 %) of those C75 years had a good
functional outcome. No significant differences between
age groups were observed for insufficient recanalization
[patients C75 vs. 18–54 years aRR 1.69 (0.95–3.03)]
and SICH [patients C75 vs. 18–54 years RR 1.77
(0.77–4.06)]. Since SICH occurred in only 42 (7 %)
patients, no further analyses were performed for this
outcome measure.
If poor functional outcome was defined as an mRS of
3–6, the proportion of patients with poor functional out-
come in each age group was 108/153 (71 %) in patients
18–54 years of age, 101/133 (76 %) in patients
55–64 years, 142/171 (83 %) in patients 65–74 years, and
137/162 (85 %) in patients C75 years. Also when this
definition was used, patients C75 years had a higher risk of
poor functional outcome [aRR 1.21 (1.07–1.36)] than
patients aged 18–54 years.
Baseline characteristics of patients C75 years and their
relationship with functional outcome are shown in
Table 4. The following variables were associated with an
increased risk of poor functional outcome after 1 month:
male sex (RR 1.18, 95 % CI 1.00–1.38), location of
occlusion (middle third vs. distal third: RR 1.21, 95 % CI
1.02–1.44), NIHSS score [20 on presentation (RR 1.36,
95 % CI 1.10–1.67), type of treatment (no treatment vs.
intra-arterial thrombolytic therapy (IAT) only: RR 1.32,
95 % CI 1.15–1.52), SICH (RR 1.21, 95 % CI 1.03–1.43),
and insufficient recanalization (RR 1.38, 95 % CI
1.07–1.77).
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The proportion of patients with poor functional outcome
in age subgroups C75 years was as follows: 64/82 (78 %)
in patients 75–79 years of age, 40/49 (82 %) in patients
80–84 years, 16/23 (70 %) in patients 85–89 years, and 7/8
(88 %) in patients 90 years or older. The oldest patient
with good functional outcome was 91 years of age, despite











Male sex 390 (63 %) 94 (61 %) 105 (79 %) 116 (68 %) 75 (46 %)
Hypertension 383 (62 %) 41 (27 %) 87 (65 %) 133 (78 %) 122 (75 %)
Diabetes mellitus 135 (22 %) 13 (8 %) 31 (23 %) 49 (29 %) 42 (26 %)
Hyperlipidemia 167 (27 %) 30 (20 %) 45 (34 %) 55 (32 %) 37 (23 %)
Atrial fibrillation 133 (21 %) 3 (2 %) 20 (15 %) 42 (25 %) 68 (42 %)
Coronary artery disease 109 (18 %) 12 (8 %) 21 (16 %) 35 (20 %) 41 (25 %)
Location of basilar artery occlusion
Distal third 202 (33 %) 42 (27 %) 30 (23 %) 55 (32 %) 75 (46 %)
Middle third 143 (23 %) 37 (24 %) 29 (22 %) 46 (27 %) 31 (19 %)
Proximal third 274 (44 %) 74 (48 %) 74 (56 %) 70 (41 %) 56 (35 %)
Median NIHSS score (IQR) 22 (12–30) 20 (9–30) 20 (12–30) 22 (13–28) 25 (16–30)
NIHSS score [20 336 (54 %) 73 (48 %) 66 (50 %) 93 (54 %) 104 (64 %)
Type of treatment
Antithrombotics 183 (30 %) 47 (31 %) 33 (25 %) 52 (30 %) 51 (31 %)
IV tPA or IV tPA/IAT 121 (20 %) 25 (16 %) 37 (28 %) 24 (14 %) 35 (22 %)
IAT only 288 (47 %) 78 (51 %) 59 (44 %) 89 (52 %) 62 (38 %)
No treatment 27 (4 %) 3 (2 %) 4 (3 %) 6 (4 %) 14 (9 %)
Time to treatment
0–3 h 179 (29 %) 41 (27 %) 39 (29 %) 49 (29 %) 50 (31 %)
4–6 h 190 (31 %) 45 (29 %) 37 (28 %) 58 (34 %) 50 (31 %)
7–9 h 84 (14 %) 22 (14 %) 19 (14 %) 26 (15 %) 17 (10 %)
10–12 h 57 (9 %) 14 (9 %) 14 (11 %) 16 (9 %) 13 (8 %)
13–24 h 55 (9 %) 17 (11 %) 15 (11 %) 9 (5 %) 14 (9 %)
[24 h 27 (4 %) 11 (7 %) 5 (4 %) 7 (4 %) 4 (2 %)
Cause of stroke
Embolism 224 (36 %) 42 (27 %) 38 (29 %) 59 (35 %) 85 (52 %)
Atherosclerosis 215 (35 %) 39 (25 %) 57 (43 %) 72 (42 %) 47 (29 %)
Dissection 32 (5 %) 24 (16 %) 5 (4 %) 3 (2 %) 0 (0 %)
Other 6 (1 %) 2 (1 %) 1 (1 %) 2 (1 %) 1 (1 %)
Unknown 142 (23 %) 44 (29 %) 30 (23 %) 31 (18 %) 27 (17 %)
NIHSS national institutes of health stroke scale, IQR interquartile range, IV intravenous, tPA tissue plasminogen activator, IAT any intra-arterial
treatment (either intra-arterial tPA, mechanical clot disruption, or both)
Fig. 1 Modified Rankin scale
scores according to age group.
mRS modified Rankin scale
score
J Neurol (2012) 259:2341–2346 2343
123
an NIHSS score of 21 on admission. This patient was
treated with intravenous recombinant tissue plaminogen
activator (rtPA) only, and had an mRS score of 2 at
1 month follow-up.
Discussion
The BASICS study shows that patients C75 years with
BAO have an increased risk of poor functional outcome
and death compared with younger patients, despite com-
parable recanalization rates. In contrast with a small pre-
vious study [6], our data show that a substantial group of
patients C75 years survives with good functional outcome.
Previously, it has been suggested that the increased risk
of poor functional outcome in elderly patients resulted
from a higher prevalence of atherosclerotic occlusions and
consequently lower recanalization rates [3]. However, in
our study population patients C75 years were more likely
to have an embolic rather than an atherosclerotic cause of
BAO, mainly due to a higher prevalence of atrial fibrilla-
tion. Patients C75 years with an embolic cause of BAO
had a similar risk of poor functional outcome compared
with patients in this age group with an atherosclerotic cause
of BAO. Sufficient recanalization was achieved in 71 % of
patients in this age group.
In patients C75 years, several baseline- and treatment-
related characteristics were associated with an increased
risk of poor functional outcome. A recent large case series
of patients with BAO, in which only a minority of patients
was C75 years, identified similar risk factors for poor
functional outcome and death [7].
Table 2 Poor functional outcome (mRS 4–6) according to age-group
18–54 yearsa 55–64 years 65–74 years C75 years
Total 153 (25 %) 133 (21 %) 171 (28 %) 162 (26 %)
Poor outcome 91/153 (60 %) 85/133 (64 %) 126/171 (74 %) 127/162 (78 %)
Unadjusted 1 1.08 (0.90–1.29) 1.24 (1.06–1.45) 1.32 (1.13–1.54)
Adjusted
Male sex 1 1.06 (0.88–1.28) 1.23 (1.05–1.45) 1.33 (1.14–1.55)
Location of occlusion 1 1.06 (0.89–1.27) 1.26 (1.08–1.47) 1.37 (1.18–1.60)
NIHSS 1 1.06 (0.90–1.25) 1.22 (1.06–1.41) 1.23 (1.06–1.41)
Time to treatment (h) 1 1.08 (0.90–1.30) 1.26 (1.07–1.49) 1.33 (1.13–1.56)
Type of treatment 1 1.07 (0.89–1.29) 1.24 (1.05–1.46) 1.32 (1.12–1.55)
3 factorsb 1 1.05 (0.89–1.24) 1.24 (1.07–1.43) 1.28 (1.11–1.48)
5 factorsc 1 1.06 (0.90–1.25) 1.28 (1.10–1.49) 1.33 (1.14–1.55)
a Reference group. Data are number (%) or risk ratio (95 % CI)
b Adjustment for national institutes of health stroke scale (NIHSS) score, sex, and location of occlusion
c Adjustment for NIHSS score, sex, location of occlusion, time to treatment, and type of treatment
Table 3 Mortality according to age group
18–54 yearsa 55–64 years 65–74 years C75 years
Total 153 (25 %) 133 (21 %) 171 (28 %) 162 (26 %)
Mortality 33/153 (22 %) 43/133 (32 %) 80/171 (47 %) 84/162 (52 %)
Unadjusted 1 1.50 (1.02–2.21) 2.17 (1.54–3.05) 2.40 (1.72–3.37)
Adjusted
Male sex 1 1.48 (1.002–2.19) 2.16 (1.53–3.04) 2.43 (1.73–3.40)
Location of occlusion 1 1.47 (0.998–2.16) 2.22 (1.58–3.11) 2.55 (1.83–3.56)
NIHSS 1 1.46 (1.008–2.12) 2.13 (1.55–2.94) 2.16 (1.57–2.98)
Time to treatment (h) 1 1.56 (1.04–2.35) 2.28 (1.59–3.27) 2.41 (1.68–3.46)
Type of treatment 1 1.55 (1.03–2.34) 2.24 (1.56–3.21) 2.42 (1.68–3.47)
3 factorsb 1 1.47 (1.02–2.12) 2.22 (1.61–3.05) 2.31 (1.68–3.17)
5 factorsc 1 1.56 (1.05–2.31) 2.41 (1.71–3.39) 2.47 (1.75–3.51)
a Reference group. Data are number (%) or risk ratio (95 % CI)
b Adjustment for national institutes of health stroke scale (NIHSS) score, sex and location of occlusion
c Adjustment for NIHSS score, sex, location of occlusion, time to treatment, and type of treatment
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The strength of this study is that BASICS was a pro-
spective registry of consecutive patients, and therefore our
results are representative for daily practice. A limitation of
this study is that this was a post hoc analysis of non-ran-
domized data, and therefore the data regarding treatment-
dependent outcomes are prone to bias. Due to the pro-
spective collection of detailed data, we were able to per-
form Poisson regression analyses to adjust for important
confounding baseline characteristics.
We conclude that a substantial group of elderly patients
survives with a good functional outcome. This study cannot
answer the question which treatment option is superior in
elderly patients, nor can it define an upper age limit above
which treatment is no longer effective. These and other
questions may be answered in the recently started BASICS
trial in which patients with BAO of up to 85 years of age
are randomized between intravenous thrombolysis (IVT)
alone vs. IVT followed by additional intra-arterial therapy
(http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=
2617; accessed February 1, 2012).
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